SCHEMBL43785

SCHEMBL43785

CC(=O)Oc1cccc(I)c1OC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.61
PTPN1 P18031 1/20 0.49
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 3/20 0.47
BLM P54132 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
APEX1 P27695 1/20 0.47
RECQL P46063 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSD17B10 Q99714 3/20 0.47
PTGS2 P35354 3/20 0.47
HPGD P15428 2/20 0.47
ESR1 P03372 1/20 0.47
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47
HMGB1 P09429 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29385313 1.00 MAPK1 (0.61) MAPK1PTPN1KDM4EALDH1A1BLM
Acetic Acid SCHEMBL28559644 0.96 MAPK1 (0.62) MAPK1PTPN1KDM4EALDH1A1BLM
Potassium Ion SCHEMBL27764600 0.96 MAPK1 (0.57) MAPK1PTPN1KDM4EALDH1A1BLM
SCHEMBL19047101 0.88 KDM4E (0.48) MAPK1KDM4EALDH1A1BLMTDP1
Benzamide SCHEMBL1114683 0.86 MAPK1 (0.51) MAPK1PTPN1KDM4EALDH1A1BLM
SCHEMBL5212814 0.86 MAPK1 (0.71) MAPK1PTPN1KDM4EALDH1A1BLM
SCHEMBL8897061 0.85 MAPK1 (0.50) MAPK1PTPN1KDM4EALDH1A1BLM
SCHEMBL6693607 0.82 MAPK1 (0.49) MAPK1PTPN1KDM4EALDH1A1BLM
SCHEMBL31604474 0.82 PTGS2 (0.57) MAPK1KDM4EALDH1A1BLMTDP1
SCHEMBL177166 0.82 PTGS2 (0.57) MAPK1KDM4EALDH1A1BLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4756 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637469-B2 1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2026-05-26 US claimed
CN-116813686-B Asymmetric synthesis method and application of 7-oxo-resorcinol lactone 欣凯医药化工中间体(上海)有限公司 2026-05-15 CN claimed
US-12590049-B2 Metal-free oxidation of pyrenes ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2026-03-31 US claimed
US-20260034125-A1 N-PHENYL-1-(PHENYLSULFONYL)PIPERIDIN-4-AMINE DERIVATIVES AS CCR6 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2026-02-05 US claimed
EP-4661964-A1 COMPOUNDS AS CCR6 INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-12-17 EP claimed
US-20250353859-A1 COMPOUNDS AS CCR6 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2025-11-20 US claimed
EP-4630402-A1 SULFONYL DERIVATIVES AS CCR6 INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-10-15 EP claimed
EP-4626866-A1 NOVEL TRILACICLIB INTERMEDIATES, METHOD OF PREPARATION AND USE THEREOF Assia Chemical Industries Ltd. (IL) 2025-10-08 EP claimed
EP-4601744-A1 NEW COMPOUNDS, PROCESSES FOR PREPARING THE SAME AND THEIR USE AS DRUGS B&A Oncomedical (FR) 2025-08-20 EP claimed
US-20250197439-A1 DECARBOXYLATIVE ACETOXYLATION USING MN(II) OR MN(III) REAGENT FOR SYNTHESIS OF 4'-ACETOXY-NUCLEOSIDE AND USE THEREOF FOR SYNTHESIS OF CORRESPONDING 4'-(DIMETHOXYPHOSPHORYL)METHOXY-NUCLEOTIDE DICERNA PHARMACEUTICALS, INC. (US) 2025-06-19 US claimed
WO-2002096898-A2 PROCESS FOR THE PREPARATION OF PROSTAGLANDINS AND ANALOGUES THEREOF RESOLUTION CHEMICALS LIMITED (GB) 2002-12-05 WO claimed
WO-2002022646-A9 METHOD FOR THE PREPARATION OF 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP) APPLIED RESEARCH SYSTEMS (NL) 2002-09-19 WO claimed
US-6399776-B2 Processes and intermediates in the synthesis of 5-(3-exo-bicyclo[2.2.1]hept-2-yloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-one PFIZER INC 2002-06-04 US claimed
WO-2002022646-A2 METHOD FOR THE PREPARATION OF 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2002-03-21 WO claimed
US-20010041798-A1 Processes and intermediates in the synthesis of 5-(3-{exo-bicyclo{2.2.1}hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6- tetrahydropyrimidin-2(1H)-one LACOUR THOMAS G (US) 2001-11-15 US claimed
US-5703230-A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same UNIVERSITY OF BRITISH COLUMBIA (CA) 1997-12-30 US claimed
EP-0794954-A1 MESO-MONOIODO-SUBSTITUTED TETRAMACROCYCLIC COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME QUADRA LOGIC TECHNOLOGIES INC. (CA) 1997-09-17 EP claimed
EP-0775119-A1 PROCESSES AND INTERMEDIATES IN THE SYNTHESIS OF 5-(3- EXO-BICYCLO 2.2.1]HEPT-2-YLOXY]-4-METHOXYPHENYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-2(1H)-ONE PFIZER INC. (US) 1997-05-28 EP claimed
WO-1996016966-A1 MESO-MONOIODO-SUBSTITUTED TETRAMACROCYCLIC COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME QUADRA LOGIC TECHNOLOGIES, INC. (CA) 1996-06-06 WO claimed
WO-1996004253-A1 PROCESSES AND INTERMEDIATES IN THE SYNTHESIS OF 5-(3-[EXO-BICYCLO[2.2.1]HEPT-2-YLOXY]-4-METHOXYPHENYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-2(1H)-ONE PFIZER INC. (US) 1996-02-15 WO claimed